XML 18 R8.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net income $ 37,753 $ 34,852
Adjustments to reconcile net income to net cash provided by operating activities:    
Gain on disposition of property (181) 0
Depreciation and amortization of deferred leasing costs 24,030 24,130
Amortization of deferred debt costs 1,145 1,122
Non-cash compensation costs of stock and option grants 724 843
Credit losses (recoveries) on operating lease receivables, net 515 (27)
Decrease in accounts receivable and accrued income 2,189 4,401
Additions to deferred leasing costs (4,174) (2,486)
Decrease in other assets 3,323 3,315
Increase in accounts payable, accrued expenses and other liabilities 2,967 3,875
Decrease in deferred income (2,332) (1,333)
Net cash provided by operating activities 65,959 68,692
Cash flows from investing activities:    
Additions to real estate investments (10,889) (14,109)
Additions to development and redevelopment projects (79,486) (85,257)
Proceeds from disposition of property 181 0
Net cash used in investing activities (90,194) (99,366)
Cash flows from financing activities:    
Proceeds from mortgage notes payable 100,000 15,300
Repayments on mortgage notes payable (68,036) (25,614)
Proceeds from revolving credit facility 51,000 78,000
Repayments on revolving credit facility (91,000) (23,000)
Proceeds from construction loans payable 64,302 28,421
Additions to deferred debt costs (1,947) (421)
Proceeds from the issuance of:    
Common stock 1,162 1,087
Partnership units 13,275 0
Distributions to:    
Common stockholders (28,428) (28,336)
Noncontrolling interests (12,040) (10,972)
Net cash provided by financing activities 22,691 28,868
Net decrease in cash and cash equivalents (1,544) (1,806)
Cash and cash equivalents, beginning of period 8,407 13,279
Cash and cash equivalents, end of period 6,863 11,473
Supplemental disclosure of cash flow information:    
Cash paid for interest 23,972 22,676
Accrued capital expenditures included in accounts payable, accrued expenses, and other liabilities 43,494 26,364
Series D Cumulative Redeemable, 30,000 shares issued and outstanding    
Distributions to:    
Preferred stockholders (2,297) (2,297)
Series E Cumulative Redeemable, 44,000 shares issued and outstanding    
Distributions to:    
Preferred stockholders $ (3,300) $ (3,300)